Hepion Pharmaceuticals, Inc.

NASDAQ:HEPA

0.6344 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q12017 Q42017 Q32017 Q22017 Q12016 Q42016 Q32016 Q22016 Q12015 Q42015 Q32015 Q22015 Q12014 Q42014 Q32014 Q22014 Q12013 Q42013 Q3
Revenue 000.1100000000000000000000000000000000000000000
Cost of Revenue 00.0310.0120.0190.0180.0180.0180.0180.0190.0230.0230.0230.0210.018000000000000000000000000000000
Gross Profit 0-0.0310.097-0.019-0.018-0.018-0.018-0.018-0.019-0.023-0.023-0.023-0.021-0.018000000000000000000000000000000
Gross Profit Ratio 000.88800000000000000000000000000000000000000000
Reseach & Development Expenses 7.1372.545.4438.51911.8819.7987.5165.7415.7024.3116.915.84.1863.4992.6273.7832.952.6371.0640.8460.7560.5181.0422.1682.1232.2613.23.9633.262.9454.3183.134.0253.1874.0423.7663.592.6061.8240.3840.2190.0730.0090.014
General & Administrative Expenses 1.3672.6431.7762.1462.2853.4120.3862.7252.4252.9412.092.7172.6692.5332.3262.4481.8251.551.1781.0640.941.4041.9531.6851.7611.6011.4831.8751.9561.9641.7051.7471.771.4661.4721.0791.7851.7921.2810.6980.6510.3860.1540.167
Selling & Marketing Expenses 0-0.031000000000000000000000000000000000000000000
SG&A 1.3672.6121.7762.1462.2853.4120.3862.7252.4252.9412.092.7172.6692.5332.3262.4481.8251.551.1781.0640.941.4041.9531.6851.7611.6011.4831.8751.9561.9641.7051.7471.771.4661.4721.0791.7851.7921.2810.6980.6510.3860.1540.167
Other Expenses -003.19000000000000000-0.004-0.022-0.094-0.06-0.126-0.0150.0320000000000000000000
Operating Expenses 8.5045.1527.21910.66514.16613.2097.9028.46518.1277.25298.5176.8556.0314.9536.2314.7754.1872.2421.9111.6961.9222.9963.8533.8843.8623.6855.8385.2164.9086.0224.8775.7944.6535.5144.8445.3754.3983.1041.0830.870.4590.1630.18
Operating Income -8.504-5.182-10.409-10.665-14.166-13.209-9.773-8.465-19.998-7.252-9-8.517-6.855-6.031-4.953-6.231-4.775-4.187-2.242-1.911-1.696-1.922-2.996-3.853-3.884-3.862-4.683-5.838-5.216-4.908-6.022-4.877-5.794-4.653-5.514-4.844-5.375-4.398-3.104-1.083-0.87-0.459-0.163-0.18
Operating Income Ratio 00-94.85600000000000000000000000000000000000000000
Total Other Income Expenses Net 4.579-0.641-4.2480.140.088-0.048-1.791-0.08-1.7810.325-0.731-0.75-0.81-0.030.009-0.046-0.069-0.040.0810.1060.1550.0360.4753.7510.0870.6350.9990.0647.266-2.71-0.3910.060.5880.7352.4840000-0.3885.251-8.846-0.005-0.002
Income Before Tax -3.925-5.823-11.469-10.527-14.08-13.26-9.695-8.548-19.911-6.93-9.733-9.269-7.667-6.064-4.959-6.294-4.845-4.227-2.161-1.82-1.982-1.984-2.573-0.157-4.029-3.226-3.685-5.7742.05-7.619-6.413-4.817-5.206-3.917-3.03-4.844-5.375-4.398-3.104-1.474.381-9.312-0.168-0.182
Income Before Tax Ratio 00-104.51700000000000000000000000000000000000000000
Income Tax Expense 0-2.969-0.409-0.1380.0020.002-2.8840.0820.0030.0020.0020.0020.0020.002-0.003-0.0620.0960-0.266-0.007-0.9610.039-0.5490.0410.264-0.5361.948-0.064-7.2662.71-1.908-0.06-0.588-0.735-2.48400000.388-00.006-0.163-0.18
Net Income -3.925-2.854-11.06-10.527-14.08-13.26-6.811-8.548-19.911-6.93-9.733-9.269-7.667-6.064-4.956-6.232-4.94-4.227-1.894-1.82-1.021-1.984-2.573-0.157-4.029-2.69-1.737-5.7742.05-7.619-4.505-4.817-5.206-3.917-3.03-4.844-5.375-4.398-3.104-1.474.381-9.312-0.168-0.182
Net Income Ratio 00-100.78900000000000000000000000000000000000000000
EPS -0.68-0.56-2.42-2.74-3.68-3.48-1.79-2.24-5.22-1.82-2.55-2.43-2.01-2.32-5.89-13.81-11.63-19.45-10.64-10.54-23.75-158.62-233.88-15.52-528.96-372.08-157.9-844.550-1,347.95-840.26-1,423.010-1,607.51-1,274.36-2,434.390-2,212.19-1,561.59-815.080-7,081.19-101.97-110.41
EPS Diluted -0.68-0.56-2.42-2.74-3.68-3.48-1.79-2.24-5.22-1.82-2.55-2.43-2.01-2.32-5.89-13.81-11.63-19.45-10.6-10.54-23.75-158.62-218.5-15.52-528.96-372.08-148.23-844.550-1,347.95-840.26-1,423.010-1,607.51-1,274.36-2,434.390-2,212.19-1,561.59-815.080-7,081.19-101.97-110.41
EBITDA -8.504-5.152-7.026-10.786-14.147-13.191-7.883-8.368-18.109-7.23-8.976-8.494-6.833-6.013-4.939-6.224-4.768-4.18-2.239-1.925-1.781-1.977-3.592-3.862-3.848-4.492-4.678-5.897-12.476-2.189-5.625-4.93-6.377-5.383-7.992-4.839-5.37-4.393-3.101-0.692-6.128.387-0.163-0.18
EBITDA Ratio 00-64.03300000000000000000000000000000000000000000